Grove Biopharma
Grove is pioneering Bionic Biologics, a breakthrough synthetic drug modality that can penetrate cells and reach protein-protein interactions that drive disease.
$30M Series A ·
Led by DCVC Bio · Source: fundraisingfox.com
Funding history ↓Signals
Website registeredOct 30, 2019 (7 years old)
Funding rounds
| Date | Round | Amount | Lead | Source |
|---|---|---|---|---|
| Series A | $30M | fundraisingfox.com |
Timeline
- Website created
Founders and team
PA
Paul A. Bertin Co-Founder, President & CTOLinkedIn · source: grovebiopharma.comGD
Geoff Duyk Founder- PNProfessor Nathan Gianneschi Co-Founder, Professorsource: grovebiopharma.com
YZ
Yuan Zhang Head of R&D Operations and External Research
Investors
DDCVC Biolead investor
DDeepWork Capital
EEli Lilly
GGradiant corporation
IInVivium Capital
JJoseph Mansueto
MMansueto Investments
SSkydeck Capitalaccelerator
VViva BioInnovator
WWalder Ventures
Companies like Grove Biopharma
GGlycoEra$130M Series B+ · May 2025
GGate BioSeed · Nov 2023AAI Proteins$41.5M Series A · Nov 2025
OORF Biologics$1.73M Seed · Jul 2026
AAccipiter Biosciences$12.7M Seed · Nov 2025SSpecific Biologics$35M Series A · Nov 2026
Other companies backed by DCVC Bio
LLatus Bio$97M Series A · May 2026
AAgZen$10M Series B+ · Mar 2026
NNilo Therapeutics$101M Series A · Oct 2025
UUmoja Biopharma$100M Series B+ · Jan 2025
NnChroma Bio$75M · Dec 2024
UUnlearn$50M Series B+ · Feb 2024
Sources and API
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/grove-biopharma (get a free API key).